Today GENALICE and Knome, Inc. USA jointly announced that the Swiss Foundation for People with Rare Diseases has chosen to use their solutions in tandem to improve the Foundation’s processing and analysis of their Next-Generation Sequencing (NGS) data.
from Technology - United States - Latest News http://ift.tt/1oA8QPa
via IFTTT
from Technology - United States - Latest News http://ift.tt/1oA8QPa
via IFTTT
No comments:
Post a Comment